# Treatment of Hypertension in Tibetan Adult Population

Study · id `cardio:ct-nct02217852` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02217852](<https://clinicaltrials.gov/study/NCT02217852>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02217852

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.

## Technical summary

Registry record NCT02217852. Randomized; no masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2016-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 800 participants (planned count; ClinicalTrials.gov record NCT02217852, source copy `cardio:ctgov-nct02217852-2014-08-29`, retrieved 2026-10-26)
- Start date: 2014-08 (registry gives no type) (ClinicalTrials.gov record NCT02217852, source copy `cardio:ctgov-nct02217852-2014-08-29`, retrieved 2026-10-26)
- Primary completion: 2016-01 (anticipated) (ClinicalTrials.gov record NCT02217852, source copy `cardio:ctgov-nct02217852-2014-08-29`, retrieved 2026-10-26)
- Completion: 2016-07 (anticipated) (ClinicalTrials.gov record NCT02217852, source copy `cardio:ctgov-nct02217852-2014-08-29`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02217852, source copy `cardio:ctgov-nct02217852-2014-08-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02217852-2014-08-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Treatment of Hypertension in Tibetan Adult Population
- Condition: Hypertension
- Intervention (Drug): Nitrendipine
- Intervention (Drug): Hydrochlorothiazide
- Intervention (Drug): Captopril,Hydrochlorothiazide
- Intervention (Drug): Beijing hypotensive No.0
- Lead sponsor: West China Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Hydrochlorothiazide (`cardio:hydrochlorothiazide`)
- Registry lists this organization as the lead sponsor: West China Hospital (`cardio:org-west-china-hospital`)

## Provenance

Content hash: b2ffa1e3c5f1c0a5a820812ea3801e82283dce769e8d7a093ac2723cd552d48e
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
